Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2

키워드

참고문헌 (47)

1. Galdiero F, "Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer", Oncotarget, 6, pp.19328~19335 (2015)
2. Zhou ES, "Evaluation and treatment of insomnia in adult cancer survivorship programs", J Cancer Surviv, 11, pp.74~79 (2017)
3. James MI, "Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy", Cancer Lett, 364, pp.135~141 (2015)
4. Tran KQ, "Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling", Anticancer Drugs, 25, pp.270~281 (2014)
5. Frémont L, "Biological effects of resveratrol", Life Sci, 66, pp.663~673 (2000)
6. Maxwell S, "Red wine and antioxidant activity in serum", Lancet, 344, pp.193~194 (1994)
7. Aggarwal BB, "Role of resveratrol in prevention and therapy of cancer : preclinical and clinical studies", Anticancer Res, 24(5A), pp.2783~2840 (2004)
8. Zhu W, "Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer", Nutr Cancer, 64, pp.393~400 (2012)
9. Opipari AW Jr, "Resveratrol-induced autophagocytosis in ovarian cancer cells", Cancer Res, 64, pp.696~703 (2004)
10. Bartel DP, "MicroRNAs : target recognition and regulatory functions", Cell, 136, pp.215~233 (2009)
11. Sheth S, "Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt", MicroRNA-21 pathway, 2012, pp.7, e51655~
12. Wu H, "Resveratrol induces cancer cell apoptosis through MiR-326", PKM2-mediated ER stress and mitochondrial fission, 2016, pp.64, 9356~9367
13. Yu YH, "MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol", Oncogene, 32, pp.431~443 (2013)
14. Tili E, "Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells", Biochem Pharmacol, 80, pp.2057~2065 (2010)
15. Peng J, "MicroRNA-26a protects vascular smooth muscle cells against H2O2-induced injury through activation of the PTEN", AKT, Int J Mol Med, pp.2018, 42[DOI]
16. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
17. Wang X, "miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer’s disease, inhibits Bcl2 translation", Brain Res Bull, 80, pp.268~273 (2009)
18. Lai YJ, "Expression of survivin and p53modulates honokiol-induced apoptosis in colorectal cancer cells", J Cell Biochem, 115, pp.1888~1899 (2014)
19. Kumazaki M, "Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells", J Nutr Biochem, 24, pp.1849~1858 (2013)
20. Csiszar A, "Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells : role of NF-kappaB inhibition", Am J Physiol Heart Circ Physiol, 291, pp.H1694~9 (2006)
21. Yousef M, "Effects of resveratrol against lung cancer : in vitro and in vivo studies", Nutrients, 9, pp.1231~ (2017)
22. Ko JH, "The role of resveratrol in cancer therapy", Int J Mol Sci, 18, pp.2589~ (2017)
23. Bishayee A, "Cancer prevention and treatment with resveratrol : from rodent studies to clinical trials", Cancer Prev Res (Phila), 2, pp.409~418 (2009)
24. Patel KR, "Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients", Cancer Res, 70, pp.7392~7399 (2010)
25. Wu ML, "Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells", PLoS One, 9, pp.e89806~ (2014)
26. Sun Z, "Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells", FEBS J, 279, pp.2381~2392 (2012)
27. Liu Y, "Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK", mTOR signaling pathway, 2018, pp.119, 6162~6172
28. Yan B, "Resveratrol inhibits ROS-promoted activation and glycolysis of pancreatic stellate cells via suppression of miR-21", Oxid Med Cell Longev, 2018, pp.1346958~ (2018)
29. Venkatadri R, "Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death", Cell Death Dis, 7, pp.e2104~ (2016)
30. Jia XN, "MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3", Eur Rev Med Pharmacol Sci, 23, pp.3270~3276 (2019)
31. Zhang R, "Down-regulation of miR-338-3p and up-regulation of MACC1 indicated poor prognosis of epithelial ovarian cancer patients", J Cancer, 10, pp.1385~1392 (2019)
32. Salem M, "miR-590-3p targets cyclin G2 and FOXO3 to promote ovarian cancer cell proliferation, invasion, and spheroid formation", Int J Mol Sci, 20, pp.1810~ (2019)
33. He L, "A microRNA component of the p53 tumour suppressor network", Nature, 447, pp.1130~1134 (2007)
34. Bommer GT, "p53-mediated activation of miRNA34 candidate tumor-suppressor genes", Curr Biol, 17, pp.1298~1307 (2007)
35. Zhao K, "Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer", J Thorac Dis, 9, pp.3735~3746 (2017)
36. Xu Y, "A potentially functional polymorphism in the promoter region of miR-34b", c is associated with an increased risk for primary hepatocellular carcinoma, 2011, pp.128, 412~417
37. Welponer H, "The miR-34 family and its clinical significance in ovarian cancer", J Cancer, 11, pp.1446~1456 (2020)
38. Geng D, "MiR-34a inhibits viability and invasion of human papillomavirus-positive cervical cancer cells by targeting E2F3 and regulating survivin", Int J Gynecol Cancer, 25, pp.707~713 (2015)
39. Sun TY, "miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma", Am J Transl Res, 9, pp.103~114 (2017)
40. Si W, "MiR-34a inhibits breast cancer proliferation and progression by targeting Wnt1 in Wnt", β-catenin signaling pathway, 2016, pp.352, 191~199
41. Lv T, "miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1", Biochem Cell Biol, 96, pp.663~671 (2018)
42. Li C, "Influence of microRNA-34a on proliferation, invasion and metastasis of HCT116cells", Mol Med Rep, 15, pp.833~838 (2017)
43. Werner TV, "MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2", Aging (Albany NY), 9, pp.932~954 (2017)
44. Ding N, "NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p", BCL2, 2017, pp.10, 4905~4915
45. Soong TR, "Frontiers in the pathology and pathogenesis of ovarian cancer : cancer precursors and"Precursor Escape"", Hematol Oncol Clin North Am, 32, pp.915~928 (2018)
46. Kar SP, "Common genetic variation and susceptibility to ovarian cancer : current insights and future directions", Cancer Epidemiol Biomarkers Prev, 27, pp.395~404 (2018)
47. Cloven NG, "In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer", Gynecol Oncol, 92, pp.160~166 (2004)

관련 논문AI추천